← Leaderboards
Katherine Ann Skorupski
University Of California, San Francisco
$1,057,482
Attributed
$3,172,446
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $636.4K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,172,446 · 1
By mechanism
R01$3,172,446 · 1
Top collaborators
- Jennifer R Grandis5 shared
- Daniel E Johnson5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Lawrence Fong$19,816,074
- Elad Ziv$19,093,596
- Rahul Aggarwal$5,953,056
- Michael John Evans$10,372,266
- Mary Helen Barcellos-Hoff$12,888,180
Others in their field
Other Emerging Leaders on “Animals”
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,986,959
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,241,299
Research focus
AnimalsAntineoplastic AgentsAntitumor EffectApoptosisBindingCell GrowthCell MaturationCell PhysiologyCell ProliferationCellsCheckpoint InhibitionClinical TrialsCytokineDendritic CellsDesignEffector T CellEvaluationExhibitsFelis CatusFoundationsFutureGenesGrowthAnimal Model
Grant awards (5)
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2023 · DE
Targeting STAT3 to enhance anti-tumor immunity$630,039
R01 · FY2022 · DE
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2021 · DE
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2020 · DE
Targeting STAT3 to enhance anti-tumor immunity$633,201
R01 · FY2019 · DE